Report Detail
COVID-19 Impact on Global Colorectal Cancer Drugs Market Insights, Forecast to 2026
- RnM4072169 |
- 22 June, 2020 |
- Global |
- 149 Pages |
- QYResearch |
- Pharma & Healthcare
Colorectal Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Colorectal Cancer Drugs market is segmented into
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Segment by Application, the Colorectal Cancer Drugs market is segmented into
Radiotherapy
Chemotherapy
Regional and Country-level Analysis
The Colorectal Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Colorectal Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Colorectal Cancer Drugs Market Share Analysis
Colorectal Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Colorectal Cancer Drugs business, the date to enter into the Colorectal Cancer Drugs market, Colorectal Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
1 Study Coverage
- 1.1 Colorectal Cancer Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Colorectal Cancer Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Type
- 1.4.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
- 1.4.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
- 1.4.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
- 1.4.5 BRAF or MEK Inhibitors
- 1.4.6 Tyrosine Kinase (TKI) Inhibitors
- 1.4.7 Immunomodulators
- 1.5 Market by Application
- 1.5.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Application
- 1.5.2 Radiotherapy
- 1.5.3 Chemotherapy
- 1.6 Coronavirus Disease 2019 (Covid-19): Colorectal Cancer Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Colorectal Cancer Drugs Industry
- 1.6.1.1 Colorectal Cancer Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Colorectal Cancer Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Colorectal Cancer Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Colorectal Cancer Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Colorectal Cancer Drugs Revenue 2015-2026
- 2.1.2 Global Colorectal Cancer Drugs Sales 2015-2026
- 2.2 Colorectal Cancer Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Colorectal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Colorectal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Colorectal Cancer Drugs Competitor Landscape by Players
- 3.1 Colorectal Cancer Drugs Sales by Manufacturers
- 3.1.1 Colorectal Cancer Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Colorectal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Colorectal Cancer Drugs Revenue by Manufacturers
- 3.2.1 Colorectal Cancer Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Colorectal Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Colorectal Cancer Drugs Revenue in 2019
- 3.2.5 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Colorectal Cancer Drugs Price by Manufacturers
- 3.4 Colorectal Cancer Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Colorectal Cancer Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Colorectal Cancer Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Colorectal Cancer Drugs Sales by Type (2015-2020)
- 4.1.2 Global Colorectal Cancer Drugs Revenue by Type (2015-2020)
- 4.1.3 Colorectal Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Colorectal Cancer Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Colorectal Cancer Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Colorectal Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Colorectal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Colorectal Cancer Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Colorectal Cancer Drugs Sales by Application (2015-2020)
- 5.1.2 Global Colorectal Cancer Drugs Revenue by Application (2015-2020)
- 5.1.3 Colorectal Cancer Drugs Price by Application (2015-2020)
- 5.2 Colorectal Cancer Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Colorectal Cancer Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Colorectal Cancer Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Colorectal Cancer Drugs by Country
- 6.1.1 North America Colorectal Cancer Drugs Sales by Country
- 6.1.2 North America Colorectal Cancer Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Colorectal Cancer Drugs Market Facts & Figures by Type
- 6.3 North America Colorectal Cancer Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Colorectal Cancer Drugs by Country
- 7.1.1 Europe Colorectal Cancer Drugs Sales by Country
- 7.1.2 Europe Colorectal Cancer Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Colorectal Cancer Drugs Market Facts & Figures by Type
- 7.3 Europe Colorectal Cancer Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Colorectal Cancer Drugs by Region
- 8.1.1 Asia Pacific Colorectal Cancer Drugs Sales by Region
- 8.1.2 Asia Pacific Colorectal Cancer Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Colorectal Cancer Drugs by Country
- 9.1.1 Latin America Colorectal Cancer Drugs Sales by Country
- 9.1.2 Latin America Colorectal Cancer Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Colorectal Cancer Drugs Market Facts & Figures by Type
- 9.3 Central & South America Colorectal Cancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Colorectal Cancer Drugs by Country
- 10.1.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country
- 10.1.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 AB Science
- 11.1.1 AB Science Corporation Information
- 11.1.2 AB Science Description, Business Overview and Total Revenue
- 11.1.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AB Science Colorectal Cancer Drugs Products Offered
- 11.1.5 AB Science Recent Development
- 11.2 Amgen
- 11.2.1 Amgen Corporation Information
- 11.2.2 Amgen Description, Business Overview and Total Revenue
- 11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Amgen Colorectal Cancer Drugs Products Offered
- 11.2.5 Amgen Recent Development
- 11.3 Array BioPharma
- 11.3.1 Array BioPharma Corporation Information
- 11.3.2 Array BioPharma Description, Business Overview and Total Revenue
- 11.3.3 Array BioPharma Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
- 11.3.5 Array BioPharma Recent Development
- 11.4 Bayer
- 11.4.1 Bayer Corporation Information
- 11.4.2 Bayer Description, Business Overview and Total Revenue
- 11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Bayer Colorectal Cancer Drugs Products Offered
- 11.4.5 Bayer Recent Development
- 11.5 Boehringer Ingelheim
- 11.5.1 Boehringer Ingelheim Corporation Information
- 11.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
- 11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
- 11.5.5 Boehringer Ingelheim Recent Development
- 11.6 Bristol-Myers Squibb
- 11.6.1 Bristol-Myers Squibb Corporation Information
- 11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
- 11.6.5 Bristol-Myers Squibb Recent Development
- 11.7 Elli Lilly
- 11.7.1 Elli Lilly Corporation Information
- 11.7.2 Elli Lilly Description, Business Overview and Total Revenue
- 11.7.3 Elli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
- 11.7.5 Elli Lilly Recent Development
- 11.8 Roch
- 11.8.1 Roch Corporation Information
- 11.8.2 Roch Description, Business Overview and Total Revenue
- 11.8.3 Roch Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Roch Colorectal Cancer Drugs Products Offered
- 11.8.5 Roch Recent Development
- 11.9 Hutchison MediPharma
- 11.9.1 Hutchison MediPharma Corporation Information
- 11.9.2 Hutchison MediPharma Description, Business Overview and Total Revenue
- 11.9.3 Hutchison MediPharma Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
- 11.9.5 Hutchison MediPharma Recent Development
- 11.10 Merck & Co., Inc.
- 11.10.1 Merck & Co., Inc. Corporation Information
- 11.10.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
- 11.10.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
- 11.10.5 Merck & Co., Inc. Recent Development
- 11.1 AB Science
- 11.1.1 AB Science Corporation Information
- 11.1.2 AB Science Description, Business Overview and Total Revenue
- 11.1.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AB Science Colorectal Cancer Drugs Products Offered
- 11.1.5 AB Science Recent Development
- 11.12 Regeneron
- 11.12.1 Regeneron Corporation Information
- 11.12.2 Regeneron Description, Business Overview and Total Revenue
- 11.12.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Regeneron Products Offered
- 11.12.5 Regeneron Recent Development
- 11.13 Sanofi
- 11.13.1 Sanofi Corporation Information
- 11.13.2 Sanofi Description, Business Overview and Total Revenue
- 11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Sanofi Products Offered
- 11.13.5 Sanofi Recent Development
- 11.14 Sumitomo Dainippon
- 11.14.1 Sumitomo Dainippon Corporation Information
- 11.14.2 Sumitomo Dainippon Description, Business Overview and Total Revenue
- 11.14.3 Sumitomo Dainippon Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Sumitomo Dainippon Products Offered
- 11.14.5 Sumitomo Dainippon Recent Development
- 11.15 Taiho Pharmaceutical
- 11.15.1 Taiho Pharmaceutical Corporation Information
- 11.15.2 Taiho Pharmaceutical Description, Business Overview and Total Revenue
- 11.15.3 Taiho Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Taiho Pharmaceutical Products Offered
- 11.15.5 Taiho Pharmaceutical Recent Development
- 11.16 Vaccinogen
- 11.16.1 Vaccinogen Corporation Information
- 11.16.2 Vaccinogen Description, Business Overview and Total Revenue
- 11.16.3 Vaccinogen Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Vaccinogen Products Offered
- 11.16.5 Vaccinogen Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Colorectal Cancer Drugs Market Estimates and Projections by Region
- 12.1.1 Global Colorectal Cancer Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Colorectal Cancer Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Colorectal Cancer Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Colorectal Cancer Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Colorectal Cancer Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Colorectal Cancer Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Colorectal Cancer Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Colorectal Cancer Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Colorectal Cancer Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Colorectal Cancer Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Colorectal Cancer Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Colorectal Cancer Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Colorectal Cancer Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Colorectal Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Colorectal Cancer Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Colorectal Cancer Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Colorectal Cancer Drugs is a syndicated market report, published as COVID-19 Impact on Global Colorectal Cancer Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Colorectal Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
